Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

The 2022 Tandem Meetings | Chronic kidney disease in survivors of pediatric alloHSCT

Christine Duncan • 24 Apr 2022
The 2022 Tandem Meetings
General

Christine Duncan, MD, Dana-Farber Cancer Institute, Boston, MA, comments on the findings of a retrospective study investigating renal toxicity following allogeneic hematopoietic stem cell transplantation (alloHSCT) in pediatric patients with hematological malignancies. The study found that a significant number of patients suffered from chronic kidney disease following transplantation, suggesting that it may be useful to monitor pediatric patients for kidney function. This interview took place at the Transplantation & Cellular Therapy (TCT) Meetings of ASTCT™ and CIBMTR® 2022 in Salt Lake City, Utah.

More from Christine Duncan

1:29
The changing landscape of survivorship care
Christine Duncan • 24 Apr 2022

Related Videos

4:33
The EBMT Patient Advocacy Committee: Patient, Family and Donor Day at EBMT 2024
Natacha Bolaños • 16 Apr 2024
2:55
Distinguishing late-onset neutropenia from classical primary neutropenia
Carlo Dufour • 15 Apr 2024
2:39
The MAGIC algorithm probability to predict outcomes of GvHD in the GI tract
James Ferrara • 16 Apr 2024
2:25
The EBMT Trainee Committee: in-person trainee day at EBMT 2024 and upcoming initiatives
Claire Horgan • 15 Apr 2024
The content of VJHemOnc is intended for healthcare professionals